Cite
HARVARD Citation
Rizvi, A. et al. (2022). Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Expert opinion on drug safety. 21 (3), pp. 291-293. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rizvi, A. et al. (2022). Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Expert opinion on drug safety. 21 (3), pp. 291-293. [Online].